Skip to content

Trial to Show Non-inferiority / Superiority of an Endoscopic Transforaminal Discectomy to Standard Microdiscectomy

Transforaminal Endoscopic Surgery Cost Outcome Research Trial

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01622413
Acronym
TESCORT
Enrollment
0
Registered
2012-06-19
Start date
2013-09-30
Completion date
2017-09-22
Last updated
2017-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Disc Herniation

Keywords

lumbar spine, herniated disc, slipped disc, disc herniation, discectomy, nucleotomy, disc surgery, endoscopy, spine

Brief summary

This study compares an endoscopic transforaminal surgical technique for the treatment of a herniated disc to the standard microsurgical procedure. Clinical parameters as well as health economy will be assessed. The study hypothesis is that the endoscopic approach is equivalent or superior to microdiscectomy.

Interventions

PROCEDUREjoimax TESSYS

Transforaminal Endoscopic Surgery System

Standard procedure for disc surgery

Sponsors

Joimax GmbH
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* symptomatic lumbar disc herniation * clinical and radiological evidence of nerve root compression * failure of conservative treatment for at least 6 weeks

Exclusion criteria

* previous lumbar spine surgery * severe or progressive motor deficit * BMI \> 40 * cauda equina syndrome

Design outcomes

Primary

MeasureTime frame
Change from baseline in Oswestry Disability Index at 4 yearstotal follow-up period of 4 years

Secondary

MeasureTime frame
Change from baseline in Quality of Life (SF-12)total follow-up period of 4 years
Health resources consumptiontotal follow-up period of 4 years
Complication rate2 years
Patient satisfactionTotal follow-up period of 4 years
Change from baseline in back and leg pain (NRS)total follow-up period of 4 years

Countries

Austria, Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026